Lindbrook Capital’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2K Sell
26
-6
-19% -$550 ﹤0.01% 2284
2024
Q4
$3.1K Hold
32
﹤0.01% 2167
2024
Q3
$3.03K Buy
32
+22
+220% +$1.92K ﹤0.01% 2215
2024
Q2
$834 Hold
10
﹤0.01% 2515
2024
Q1
$859 Hold
10
﹤0.01% 2447
2023
Q4
$826 Hold
10
﹤0.01% 2507
2023
Q3
$719 Hold
10
﹤0.01% 2444
2023
Q2
$758 Sell
10
-4
-29% -$269 ﹤0.01% 2421
2023
Q1
$884 Sell
14
-1
-7% -$59 ﹤0.01% 2485
2022
Q4
$815 Hold
15
﹤0.01% 2502
2022
Q3
$1K Hold
15
﹤0.01% 2205
2022
Q2
$1K Buy
+15
New +$786 ﹤0.01% 2123
2022
Q1
Sell
-24
Closed -$1K 2459
2021
Q4
$1K Hold
24
﹤0.01% 1860
2021
Q3
$1K Buy
+24
New +$1.24K ﹤0.01% 1660

Other funds holding ACA

Lindbrook Capital's ACA Position: Q1 2025 in Review

Lindbrook Capital reduced its Arcosa (ACA) stake by 19% in Q1 2025, selling an estimated $550 and leaving 26 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2284.

Lindbrook Capital first reported a position in ACA in Q3 2021 and has held it in 14 quarters since. The position peaked at $3.1K in Q4 2024. 314 funds tracked by Wall St. Rank hold ACA as of Q1 2025.

  • Lindbrook Capital held 26 shares of Arcosa worth $2K as of Q1 2025.
  • Lindbrook Capital sold 6 Arcosa shares in Q1 2025, an estimated $550.
  • Arcosa made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2284 holding.
  • Lindbrook Capital first reported a position in Arcosa in Q3 2021 and has held it in 14 quarters since.
  • Lindbrook Capital's Arcosa position peaked at $3.1K in Q4 2024.
  • 314 funds tracked by Wall St. Rank held Arcosa as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.